Anixa Biosciences (ANIX) Return on Equity [ROE] (2011 - 2026)
Anixa Biosciences (ANIX) reported Return on Equity [ROE] of -73.39% for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 0.62 percentage points from -74.01% a year earlier but down 0.46 percentage points from the prior quarter.
Powered by 
Analysis
Anixa Biosciences (ANIX) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025 (ended Oct 31, 2025), Anixa Biosciences posted Return on Equity [ROE] of -64.78%, down 4.68 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of +89.58 percentage points (FY2020 to FY2025).
- By fiscal year, Return on Equity [ROE] came in at -60.10% in FY2024 (-21.59 pp), -38.51% in FY2023 (+5.23 pp), -43.74% in FY2022 (+17.28 pp) and -61.02% in FY2021 (+93.34 pp).
- Five-year quarterly Return on Equity [ROE] spans a low of -77.51% in fiscal Q2 2025 and a high of -37.18% in fiscal Q4 2021.
- Year over year, Return on Equity [ROE] gained in two of the last seven quarters, with an average year-over-year change of -13.29 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was fiscal Q4 2021 (a gain of 85.88 percentage points); the low point was fiscal Q2 2025 (a drop of 26.68 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Anixa Biosciences | 102.02 Mn | 100.75 Mn | - | -73.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -73.39% |
| Apr 30, 2026 | -72.93% |
| Oct 31, 2025 | -72.14% |
| Jul 31, 2025 | -74.01% |
| Apr 30, 2025 | -77.51% |
| Jan 31, 2025 | -70.90% |
| Oct 31, 2024 | -64.17% |
| Jul 31, 2024 | -57.80% |
| Apr 30, 2024 | -50.83% |
| Jan 31, 2024 | -46.26% |
| Oct 31, 2023 | -41.41% |
| Jul 31, 2023 | -42.53% |
| Apr 30, 2023 | -41.51% |
| Jan 31, 2023 | -44.44% |
| Oct 31, 2022 | -46.60% |
| Jul 31, 2022 | -45.94% |
| Apr 30, 2022 | -49.27% |
| Jan 31, 2022 | -43.45% |
| Oct 31, 2021 | -37.18% |
| Jul 31, 2021 | -30.99% |
API Access
Anixa Biosciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();